PACS Group (NYSE:PACS) Coverage Initiated at Citigroup

Equities research analysts at Citigroup assumed coverage on shares of PACS Group (NYSE:PACS) in a research report issued to clients and investors on Monday, Marketbeat.com reports. The brokerage set a “buy” rating and a $32.00 price target on the stock. Citigroup’s target price points to a potential upside of 28.05% from the company’s current price.

A number of other analysts have also recently issued reports on the company. Royal Bank of Canada started coverage on PACS Group in a research note on Monday. They set an “outperform” rating and a $30.00 target price for the company. Oppenheimer started coverage on PACS Group in a research note on Monday. They set an “outperform” rating and a $31.00 target price for the company. Finally, Truist Financial started coverage on PACS Group in a research note on Monday. They set a “buy” rating and a $32.00 target price for the company. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $30.50.

PACS Group Price Performance

NYSE PACS opened at $24.99 on Monday. PACS Group has a 52-week low of $22.61 and a 52-week high of $25.72.

Insider Transactions at PACS Group

In other news, CEO Jason Hulse Murray sold 1,607,142 shares of the firm’s stock in a transaction that occurred on Monday, April 15th. The shares were sold at an average price of $21.00, for a total transaction of $33,749,982.00. Following the completion of the transaction, the chief executive officer now directly owns 62,754,551 shares of the company’s stock, valued at approximately $1,317,845,571. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.